What are the management strategies for first-degree atrioventricular (AV) block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for First-Degree AV Block

First-degree AV block is caused by medications that slow AV nodal conduction (beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, antiarrhythmics), structural heart disease (myocardial infarction, congenital heart disease), infectious diseases (Lyme disease), infiltrative diseases (sarcoidosis, amyloidosis), electrolyte disturbances, and neuromuscular diseases. 1, 2

Medication-Related Risk Factors

  • Beta-blockers are a major cause of first-degree AV block by slowing AV nodal conduction, and patients with pre-existing first-degree AV block may be at increased risk for severe bradycardia when receiving metoprolol or other beta-blocking agents 1, 2

  • Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) slow AV conduction and can precipitate or worsen first-degree AV block 1

  • Digoxin and antiarrhythmic medications commonly cause first-degree AV block through their effects on the AV node 1

  • Amiodarone should be used with caution as it slows AV conduction 3

Structural and Ischemic Heart Disease

  • Myocardial infarction, particularly inferior wall MI, is commonly associated with first-degree AV block, with the site of AV delay usually located above the bundle of His 3

  • Congenital heart disease is a significant risk factor, with first-degree AV block occurring in conditions such as repaired tetralogy of Fallot, ventricular septal defects, and congenitally corrected transposition of the great arteries 3, 1

  • Structural heart disease of any etiology increases risk, and patients with evidence of structural abnormalities should be considered for more intensive monitoring 1, 4

Infectious and Infiltrative Diseases

  • Lyme disease can affect the cardiac conduction system and cause first-degree AV block 1

  • Infiltrative diseases including sarcoidosis and amyloidosis can damage the conduction system and lead to AV block 1

Neuromuscular Diseases

  • Myotonic dystrophy and Kearns-Sayre syndrome are associated with unpredictable progression of conduction disease, and patients with these conditions require close monitoring even with first-degree AV block 1, 4

Electrolyte and Metabolic Disturbances

  • Electrolyte abnormalities can precipitate first-degree AV block and should be identified and corrected in symptomatic patients 1

Pregnancy-Related Considerations

  • Pregnancy itself can unmask first-degree AV block in the absence of underlying heart disease, though it typically has a favorable outcome and the site of delay is usually above the bundle of His without progression to complete heart block 3

  • Thirty percent of congenital AV blocks remain undiscovered until adulthood and may present during pregnancy due to increased hemodynamic demands 3

Common Pitfalls

  • Do not assume all first-degree AV block is benign—PR intervals ≥0.30 seconds can cause symptoms similar to pacemaker syndrome due to inadequate timing of atrial and ventricular contractions 1, 4, 5

  • Coexisting bifascicular block with first-degree AV block increases risk of progression to higher-degree block and warrants closer monitoring 4

  • Recent evidence suggests that first-degree AV block may be a risk marker for more severe intermittent conduction disease, with up to 40% of monitored patients showing progression to higher-grade block requiring pacemaker implantation 6

References

Guideline

Treatment of First-Degree Atrioventricular Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of First-Degree Atrioventricular Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

First-degree AV block-an entirely benign finding or a potentially curable cause of cardiac disease?

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.